Capital Advisory Group Advisory Services, LLC Vericel Corp Transaction History

Capital Advisory Group Advisory Services, LLC

$250 Million
Q3 2024

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$22.88 - $39.45 $45,760 - $78,900	-2,000 Closed	0 $0
Q1 2022 Apr 29, 2022	BUY	$31.69 - $43.29 $63,380 - $86,580	2,000 New	2,000 $76,000
Q4 2021 Feb 15, 2022	SELL	$35.2 - $52.6 $70,400 - $105,200	-2,000 Closed	0 $0
Q1 2020 May 18, 2020	BUY	$7.25 - $19.22 $14,500 - $38,440	2,000 New	2,000 $18,000
Q4 2019 Feb 14, 2020	SELL	$13.77 - $19.2 $27,540 - $38,400	-2,000 Closed	0 $0
Q2 2018 May 28, 2020	SELL	$9.6 - $14.6 $19,200 - $29,200	-2,000 Reduced 50.0%	2,000 $19,000
Q1 2018 May 28, 2020	BUY	$5.7 - $12.3 $22,800 - $49,200	4,000 New	4,000 $40,000

Others Institutions Holding VCEL

# of Institutions

276

Shares Held

48.4M

Call Options Held

91.8K

Put Options Held

23.2K

View Full List

About Vericel Corp

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $2.59B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

More about VCEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Advisory Group Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Advisory Group Advisory Services, LLC with notifications on news.

Account